Table of Content

1. Executive Summary
1.1. Global Liver Transplantation Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Type Lifecycle Analysis
2.4. Liver Transplantation Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Liver Transplantation Market Outlook: Product Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
3.3.3.1. Organ Preservation Solutions
3.3.3.2. Immunosuppressive Drugs
3.3.3.3. Others
3.4. Market Attractiveness Analysis: Product Type
3.5. Global Liver Transplantation Market Outlook: Treatment Type
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
3.5.3.1. Liver Transplantation Surgery
3.5.3.2. Post-Surgery Anti-Rejection Treatment
3.5.3.3. Cyclosporine
3.5.3.4. Tacrolimus
3.5.3.5. Sirolimus Prednisone Azathioprine
3.5.3.6. Mycophenolate Mofetil
3.6. Market Attractiveness Analysis: Treatment Type
3.7. Global Liver Transplantation Market Outlook: End-use
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-use, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
3.7.3.1. Hospitals
3.7.3.2. Adult liver transplantation centers
3.7.3.3. Ambulatory surgical centers
3.8. Market Attractiveness Analysis: End-use
4. Global Liver Transplantation Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product Type
5.3.3. By Treatment Type
5.3.4. By End-use
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
5.5.1. Organ Preservation Solutions
5.5.2. Immunosuppressive Drugs
5.5.3. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
5.6.1. Liver Transplantation Surgery
5.6.2. Post-Surgery Anti-Rejection Treatment
5.6.3. Cyclosporine
5.6.4. Tacrolimus
5.6.5. Sirolimus Prednisone Azathioprine
5.6.6. Mycophenolate Mofetil
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
5.7.1. Hospitals
5.7.2. Adult liver transplantation centers
5.7.3. Ambulatory surgical centers
5.8. Market Attractiveness Analysis
6. Europe Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product Type
6.3.3. By Treatment Type
6.3.4. By End-use
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
6.5.1. Organ Preservation Solutions
6.5.2. Immunosuppressive Drugs
6.5.3. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
6.6.1. Liver Transplantation Surgery
6.6.2. Post-Surgery Anti-Rejection Treatment
6.6.3. Cyclosporine
6.6.4. Tacrolimus
6.6.5. Sirolimus Prednisone Azathioprine
6.6.6. Mycophenolate Mofetil
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
6.7.1. Hospitals
6.7.2. Adult liver transplantation centers
6.7.3. Ambulatory surgical centers
6.8. Market Attractiveness Analysis
7. East Asia Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product Type
7.3.3. By Treatment Type
7.3.4. By End-use
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
7.5.1. Organ Preservation Solutions
7.5.2. Immunosuppressive Drugs
7.5.3. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
7.6.1. Liver Transplantation Surgery
7.6.2. Post-Surgery Anti-Rejection Treatment
7.6.3. Cyclosporine
7.6.4. Tacrolimus
7.6.5. Sirolimus Prednisone Azathioprine
7.6.6. Mycophenolate Mofetil
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
7.7.1. Hospitals
7.7.2. Adult liver transplantation centers
7.7.3. Ambulatory surgical centers
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Treatment Type
8.3.4. By End-use
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
8.5.1. Organ Preservation Solutions
8.5.2. Immunosuppressive Drugs
8.5.3. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
8.6.1. Liver Transplantation Surgery
8.6.2. Post-Surgery Anti-Rejection Treatment
8.6.3. Cyclosporine
8.6.4. Tacrolimus
8.6.5. Sirolimus Prednisone Azathioprine
8.6.6. Mycophenolate Mofetil
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
8.7.1. Hospitals
8.7.2. Adult liver transplantation centers
8.7.3. Ambulatory surgical centers
8.8. Market Attractiveness Analysis
9. Latin America Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Treatment Type
9.3.4. By End-use
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
9.5.1. Organ Preservation Solutions
9.5.2. Immunosuppressive Drugs
9.5.3. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
9.6.1. Liver Transplantation Surgery
9.6.2. Post-Surgery Anti-Rejection Treatment
9.6.3. Cyclosporine
9.6.4. Tacrolimus
9.6.5. Sirolimus Prednisone Azathioprine
9.6.6. Mycophenolate Mofetil
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
9.7.1. Hospitals
9.7.2. Adult liver transplantation centers
9.7.3. Ambulatory surgical centers
9.8. Market Attractiveness Analysis
10. Middle East & Africa Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Treatment Type
10.3.4. By End-use
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
10.5.1. Organ Preservation Solutions
10.5.2. Immunosuppressive Drugs
10.5.3. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
10.6.1. Liver Transplantation Surgery
10.6.2. Post-Surgery Anti-Rejection Treatment
10.6.3. Cyclosporine
10.6.4. Tacrolimus
10.6.5. Sirolimus Prednisone Azathioprine
10.6.6. Mycophenolate Mofetil
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
10.7.1. Hospitals
10.7.2. Adult liver transplantation centers
10.7.3. Ambulatory surgical centers
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Immunosuppressive Drugs
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Allosource
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Conatus Pharmaceuticals Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Digna Biotech S.L.
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Dompe Farmaceutici S.p.A.
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Isogenis, Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. RedHill Biopharma Ltd.
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Thompson Surgical
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Integra Life Sciences
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Baxter International Inc.
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. XVIVO
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. VirTech Bio
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. Vital Therapies
11.3.12.1. Overview
11.3.12.2. Segments and Product
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
11.3.13. HepaTx
11.3.13.1. Overview
11.3.13.2. Segments and Product
11.3.13.3. Key Financials
11.3.13.4. Market Developments
11.3.13.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations